Latest California Healthline Stories
Death By 1,000 Cuts: How Republicans Can Still Alter Your Coverage
There are many ways beyond legislative repeal for the Trump administration and congressional Republicans to unravel the Affordable Care Act.
Senators Demand Answers About Possible Probe Of HHS Secretary Price
Democratic senators want the Justice Department to reveal what it knows about ProPublica’s recent report that HHS Secretary Tom Price’s stock trades were under investigation by former U.S. Attorney Preet Bharara before the Trump administration fired him.
Popular Guarantee For Young Adults’ Coverage May Be Health Law’s Achilles’ Heel
Republicans and Democrats don’t agree on much these days, but both parties want to keep the health law’s provision to allow adults to stay on their parents’ plan until age 26. But that could be hurting the marketplace’s insurance pools.
Trump’s Promise To Rein In Drug Prices Could Open Floodgate To Importation Laws
Sen. Bernie Sanders’ bill to allow Americans to buy cheaper medicines from Canada would bypass a requirement that blocked past legislative efforts over two decades.
Report: Fired U.S. Attorney Was Probing Tom Price’s Stock Trades
The HHS Secretary bought stock in companies that stood to benefit from legislation he voted for and sponsored as a Georgia congressman.
New Rules Try To Shore Up Individual Health Insurance Market In 2018
The Trump administration’s first health regulation would shorten the enrollment periods and make it harder for patients to get coverage outside of that annual signup period.
Influence Of GOP Doctors Caucus Grows As Congress Looks To Replace Health Law
As conservative physicians rise to more powerful positions in government, some question whether they speak for the nation’s doctors.
Five Quick Ways New HHS Secretary Tom Price Could Change The Course Of Health Policy
Tom Price will have significant authority to rewrite the rules for the Affordable Care Act.
HHS Pick Price Made ‘Brazen’ Stock Trades While His Committee Was Under Scrutiny
With federal investigators bearing down on his committee, Rep. Tom Price, who is in line to be secretary of HHS, showed little restraint in investing in health companies.
Republicans Standing Behind Price
KHN’s Julie Rovner is interviewed on WBUR’s “Here and Now” about the Senate Finance Committee’s hearing on the nomination of Rep. Tom Price to head HHS, as well as President Donald Trump’s recent executive order on the health law.